Showing results (181-190 of 217) with videos related to
Sort By:
Pageof 22
Frontiers in Immunology|September 21, 2018
Mucosal Autoimmunity to Cell-Bound GP2 Isoforms Is a Sensitive Marker in PSC and Associated With the Clinical PhenotypeMandy Sowa, Rafał Kolenda, Daniel C Baumgart, et al.NPJ Digital Medicine|April 15, 2025
Network analysis of extraintestinal manifestations and associated autoimmune disorders in Crohn's disease and ulcerative colitisDaniel C Baumgart, C Hing Cheng, Tian X Du, et al.Journal of the Canadian Association of Gastroenterology|February 11, 2026
Comparing the accuracy of computed tomography enterography to balloon-assisted enteroscopy in the evaluation of small bowel Crohn's diseaseJared Cooper, Scott MacKay, Matthew Reeson, et al.Journal of Crohn'S & Colitis|October 31, 2019
Deficient Resident Memory T Cell and CD8 T Cell Response to Commensals in Inflammatory Bowel DiseaseAlistair Noble, Lydia Durant, Lesley Hoyles, et al.Microbiome|June 10, 2020
Bacteroides thetaiotaomicron-derived outer membrane vesicles promote regulatory dendritic cell responses in health but not in inflammatory bowel diseaseLydia Durant, Régis Stentz, Alistair Noble, et al.Disease Models & Mechanisms|March 1, 2019
Integrative analysis of Paneth cell proteomic and transcriptomic data from intestinal organoids reveals functional processes dependent on autophagyEmily J Jones, Zoe J Matthews, Lejla Gul, et al.Gut|June 22, 2012
A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitisPaul J Rutgeerts, Richard N Fedorak, Daan W Hommes, et al.Scientific Reports|March 11, 2025
Relating the molecular phenotype of ulcerative colitis to the clinical courseKatelynn S Madill-Thomsen, Jeffery M Venner, Denise E Parsons, et al.Cytotherapy|February 6, 2018
Proceedings of the signature series event of the international society for cellular therapy: "Advancements in cellular therapies and regenerative medicine in digestive diseases," London, United Kingdom, May 3, 2017Rachele Ciccocioppo, Claudia C Dos Santos, Daniel C Baumgart, et al.Digestive Diseases and Sciences|March 17, 2025
Long-Term Effectiveness and Safety of Ustekinumab Dose Escalation in Patients with Moderate-to-Severe Ulcerative Colitis: A Multicenter Retrospective Cohort StudyLisa M A van Lierop, Larissa Albino, Ryan Rosentreter, et al.Pageof 22